Analysis of CD16+CD56dim NK cells from CLL patients: evidence supporting a therapeutic strategy with optimized anti-CD20 monoclonal antibodies
2011
Analysis of
CD16+ CD56 dim NK cells from CLL patients: evidence supporting a therapeutic strategy with optimized anti-
CD20
monoclonal antibodies
Keywords:
-
Correction
-
Source
-
Cite
-
Save
41
References
48
Citations
NaN
KQI